Clinical trial
Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus
NCT00372957 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00372957 |
|---|---|
| Title | Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus |
| Official title | PK/PD Study of GW823093 in Japanese Subjects With T2DM: A Single-blind, Placebo Controlled, Randomized, Multi-dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GW823093C Administered Orally for 7 Days in Japanese Subjects With Type 2 Diabetes |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | GW823093 15mg, GW823093 placebo capsule, GW823093 30mg |
| Enrollment | 30 |
| Start date | Mar 22, 2006 |
| Primary completion | Jun 28, 2006 |
| Completion | Jun 28, 2006 |
| First posted | Sep 7, 2006 |
| Last update posted | Sep 4, 2018 |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: